Seamlessly Integrated

Strategy Consulting &
Investment Banking

For the Life Sciences Industry

More About Us Play the Back Bay Video

A Gutsy Combination: The Microbiome and Immuno-Oncology

A Gutsy Combination: The Microbiome and Immuno-oncologyAs science explores the effects of the microbiome on the immune system and its role in treating cancer, drug developers are investing substantially to capitalize on findings connecting the microbiome, immunology, and oncology.

For our latest white paper, Back Bay Life Science Advisors analyzed the activity of drug developers looking to harness microbial pathways to improve cancer treatment, the current drug pipeline, active clinical trials, and evolving regulatory and IP issues for the development of these technologies.

Download the white paper

Transaction Update

Sell-Side Advisor

Centrexion Therapeutics, Inc
Global licensing of CNTX-0290 to
Up to $1 Billion

Results Matter